• 18F-FDG PET/CT in Synovial Anaplastic Large Cell Lymphoma
• A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan
• ALK rearranged Spitz melanocytoma: a clinicopathological and molecular genetic analysis of two cases
• ALK-positive anaplastic large cell lymphoma of paranasal sinuses: two cases report and literature review
• An atypical case of pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma limited to the skin on chest wall detected by ultrasound
• Anaplastic Large Cell Lymphoma (ALCL) With a Sarcomatoid Variant Presenting As Distributive Shock in a 41-Year-Old Female: A Case Report
• Anaplastic Large Cell Lymphoma Growing in the Pacemaker Pocket
• Anaplastic Large Cell Lymphoma of the Spine: Report of a Rare Case
• Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report
• Anaplastic Large Cell Lymphoma Presenting as Pyoderma Gangrenosum
• Anaplastic large cell lymphoma with ALK::ATIC fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features
• Anaplastic large cell lymphoma with ATIC::ALK in leukemic phase and associated with hemophagocytic lymphohistiocytosis
• Anaplastic Large-cell Lymphoma in Children: State of the Art in 2023
• Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Non-Hodgkin Lymphoma as a Rare Differential Diagnosis of Lung Cancer: A Case Report
• B-Cell Lymphoma Arising From a Nasal Implant: A Brief Clinical Study
• Beyond surgery: the proper role and delivery of radiation therapy in the local-regional management of BIA-ALCL
• BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations
• Breast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons
• Breast implant surface topography triggers a chronic-like inflammatory response
• Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants
• Breast Implant-Associated Anaplastic Large Cell Lymphoma: Where Hematology and Plastic Surgery Meet
• Breast lymphomas: Clinical and pathological insights from a tertiary cancer care center in India
• Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
• Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis
• Brentuximab-induced pneumonitis and organizing pneumonia: a case report with literiture review
• Brigatinib in ALK-Positive ALCL after Failure of Brentuximab Vedotin
• Case report: The utilization of crizotinib and brentuximab vedotin as a bridge to autologous stem cell transplantation and followed by CD30-directed CAR-T cell therapy in relapsed/refractory ALK+ ALCL
• Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma
• Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based study
• Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC
• Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders
• Comparing Genomic Profiles of ALK Fusion-Positive and ALK Fusion-Negative Nonsmall Cell Lung Cancer Patients
• Comparison of Polytech MESMO and Motiva Ergonomix Breast Implants With a Focus on Displacement Issues: A Single Surgeon's Experience in 329 Patients
• Composite ALK-negative anaplastic large cell lymphoma and follicular lymphoma involving jejunum and mesenteric lymph nodes
• Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma
• Cutaneous Lymphoma in a Tertiary Skin Hospital and Referral Centre in Nepal
• Cutaneous T-cell Lymphoma
• Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
• Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma
• Drug eruption and cutaneous metastasis in a patient with ALK-negative anaplastic large T-cell lymphoma after tislelizumab
• DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype
• EBV-Positive Nodal T- and NK-Cell Lymphoma Mimicking Anaplastic Large Cell Lymphoma: A Case Report
• Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line
• Evaluation of sex inequity in lung-cancer-specific survival
• Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins
• Extranodal Anaplastic Large Cell Lymphoma Involving the Pancreas: A Rare Presentation
• Extravasation of brentuximab vedotin, an antibody-drug conjugate, in a patient with anaplastic large cell lymphoma
• Flow Cytometry Analysis in Breast Implant-Associated Anaplastic Large Cell Lymphoma: Three Case Reports
• From Case Reports to Molecular Insight: Examining the Outcomes and Underlying Mechanisms of Squamous Cell Carcinoma in Breast Implant Patients-A Systematic Review
• IC Regimen: Delaying Resistance to Lorlatinib in ALK Driven Cancers by Adding Repurposed Itraconazole and Cilostazol
• Identification of APPB1 as a substrate for anaplastic lymphoma kinase
• Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC
• Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008-2020
• Intraoral CD30+ T-Cell Lymphoproliferative Disorder with Lymphomatoid Papulosis Type C Features Mimics Lymphoma Histopathologically and Immunohistochemically
• Isolated Central Nervous System Involvement after Brentuximab Vedotin Treatment for HIV-Positive ALK-Negative Anaplastic Large Cell Lymphoma
• Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
• KLHL14 is a tumor suppressor downregulated in undifferentiated thyroid cancer
• Late Hematoma After Feminizing Augmentation Mammoplasty Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
• Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis
• Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature
• Metastases and Primary Brain Tumors Affecting the Fornix of the Brain
• Non-Hodgkin lymphoma presenting with spinal cord compression: A population-based analysis of the NHL-BFM study group
• Non-Hodgkin's Anaplastic Large T-Cell Lymphoma: A Case Report
• Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
• Overcoming Chemoresistance in Cancer: The Promise of Crizotinib
• p63 in primary cutaneous anaplastic large cell lymphoma
• Paediatric cutaneous lymphomas including rare subtypes: A 40-year experience at a tertiary referral centre
• Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)
• Paraneoplastic acquired ichthyosis as the first manifestation in breast implant-associated anaplastic large cell lymphoma
• Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative
• Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma
• Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors
• Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
• Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers
• Primary anaplastic large cell lymphoma arising from central nervous system
• Primary Central Nervous System Lymphoma, Treatment Outcomes - 10 Year Experience. Single Center Study
• Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report
• Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma
• Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center
• Recurrence of an erythrodermic mycosis fungoides as a biologically indolent anaplastic large T-cell lymphoma initially misdiagnosed as being of donor origin
• Repeated Fluid Accumulation around a Breast Implant Related to Synovial Metaplasia of the Capsule
• Risankizumab for the treatment of pityriasis rubra pilaris postanaplastic large cell lymphoma
• Risk of systemic lymphoma in patients with cutaneous CD30+ lymphoproliferative disorders: A single center retrospective cohort analysis
• Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma-Experience from an Indian Center
• Role of Pap Smear Cervical Cytology in the Diagnosis of Extrauterine Malignancies: Largest Study of 104 Cases from Tertiary Care Cancer Centre in India
• Severe capsular contracture in a patient with a history of multiple malignancies - Hematoma or neoplasm recurrence?: A case report
• Small cell pattern of ALK-negative anaplastic large cell lymphoma with double-hit rearrangements of DUSP22 and TP63
• Spider Bite Presenting as Fever, Macrophage Activation Syndrome and a Skin Ulcer
• Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms
• STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma
• Stratified Treatment in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study
• Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma
• Systematic under-ascertainment of anaplastic large cell lymphoma cases in cancer registries: report from a comprehensive cancer center
• The Difficulties and Ease of Diagnosing Anaplastic Large Cell Lymphomas on Cytology
• The Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma; A Systematic Review and Meta-Analysis
• The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance
• Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry
• Undifferentiated Pleomorphic Sarcoma Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma
• Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions
• Update on T-Cell Lymphoma Epidemiology